You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Pediatric Cancer Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 1 | Results 1 - 6 of 6

Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

Joanna Luty, MD
Cancer, Cancer - Pediatric

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

Joanna Luty, MD
Cancer - Pediatric, Cancer, Cancer - Leukemia

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma

Joanna Luty, MD
Cancer - Leukemia, Cancer, Cancer - Pediatric

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma

Joanna Luty, MD
Cancer - Pediatric

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

Joanna Luty, MD
Cancer - Leukemia, Cancer - Pediatric, Cancer

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

Joanna Luty, MD
Cancer, Cancer - Lymphoma, Cancer - Pediatric

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active
Page 1 of 1 | Results 1 - 6 of 6